October 2022 - Wellthy Therapeutics

Monthly Archives: October 2022

A discussion on the evolution of the DTx industry – from solutions to platforms DTx 1.0 to DTx 2.0

Digital therapeutics are taking off but are they meeting the needs of all stakeholders? Due to pharma’s vast size and their desire to ‘test and learn’ they often create multiple DTx ‘point solutions’ which leads to issues not just for themselves but also for other stakeholders. Patients  May have multiple comorbidities therefore experience ‘Digital poly-pharmacy’